Neil Sankar M.D.,MPH

Neil Sankar M.D.,MPH has been working in the medical field since 2017. Neil began at Temple Therapeutics BV as the Chief Medical Officer and Global Head of Clinical Development. In 2021, they joined Jasper Therapeutics as the Senior Medical Director and Medical Monitor Consultant. In 2022, they worked for Escend Pharmaceuticals as the Executive Medical Director and Medical Monitor Consultant, for BiOneCure as the Senior Medical Director and Medical Monitor Consultant, for Teon Therapeutics Inc. as the Senior Medical Director and Medical Monitor Consultant, for Immusoft as the Senior Medical Director and Project Medical Monitor, for Tizona Therapeutics, Inc. as the Senior Medical Director and Global Medical Monitor Consultant, and for RenovoRx as the Senior Medical Director and Medical Monitor Consultant Medical Oncology Programs. In 2023, they joined MBQ Pharma as the Contract Chief Medical Officer and Strand Therapeutics as the Senior Medical Consultant and Medical Monitor.

Neil Sankar M.D.,MPH completed a Bachelor of Medicine, Bachelor of Surgery (MBBS) at Bangalore University from 1987 to 1993. Neil then completed an Internship from 1993 to 1994. Afterwards, they completed a Residency, Doctor of Medicine, Univ of West Indies Medical Board at Kingston Public Hospital from 1994 to 1996. Neil then completed a Masters in Public Health at QUT (Queensland University of Technology) from 1997 to 1998. Finally, they completed a Medical Oncology Fellowship and Training at the National Cancer Institute from 2001 to 2003. Additionally, they obtained a Human Subjects Research Basic Course from the CITI Program in May 2021, a CCRP from SOCRA in June 2004, and a Biomedical Research Basic Course from the CITI Program in May 2021.